Podcasts about harvard global health institute

In The Social Ideas Podcast: the neo-colonialism of COVID-19, Dr Ingrid Katz shares why her tweet celebrating the work of South African researchers also criticised the ‘them vs us' attitude to medical research conducted outside of countries deemed more affluent. With AIDS, COVID-19 and the inevitability of a future pandemic, Dr Katz discusses the urgent need for a global approach to the provision of healthcare.Dr Katz is the Associate Faculty Director of the Harvard Global Health Institute and an Associate Professor at Harvard Medical School.Cambridge Centre for Social InnovationMasters in Social InnovationHarvard Medical School

This episode is brought to you by MEDHOST, a Trusted EHR for Healthcare Facilities. To learn more, go to Medhost.com. Dr. Ashish Jha is a physician, health policy researcher, and the third Dean of the Brown University School of Public Health.  Dr. Jha is recognized globally as an expert on pandemic preparedness and response, has led groundbreaking research around Ebola and is now on the frontlines of the COVID-19 response, leading national and international analysis of key issues and advising state and federal policymakers.  He previously led the Harvard Global Health Institute and teaching at the Harvard T.H. Chan School of Public Health and Harvard Medical School. You'll want to hear our discussion on the future of public health and how to address its increasing politicization.

Welcome to Contain This, brought to you by the Indo-Pacific Centre for Health Security, an initiative of the Australian Government housed at the Department of Foreign Affairs and Trade. We are proud to present our Annual Ruth Bishop Lecture, with Dr Sarthak Das APLMA.Dr Sarthak Das is the Chief Executive Officer of the Asia Pacific Leaders Malaria Alliance. Sarthak joined APLMA from the Harvard T.H. Chan School of Public Health, and continues to hold a position as Senior Advisor for research translation and Global Health Policy at the Harvard Global Health Institute.His work has spanned diverse Asia-Pacific settings, in countries such as Cambodia, India, Indonesia, Laos, Vietnam, Myanmar, and Papua New Guinea, as well as in West Africa. It's his 25 years of experience as a public health scientist, development practitioner, and global health policy advisor that inspired this lecture.You can join the conversation via our social media channels, through @CentreHealthSec and @AusAmbRHS.

When schools finished the academic year earlier this summer, they looked forward to the fall with the first cautious optimism anyone had felt in years.  But Dr. Ashish Jha has offered level-headed wisdom that the pandemic simply is not over. Ashish K. Jha, MD, MPH, is a physician, health policy researcher, and the Dean of the Brown University School of Public Health.  Before joining Brown, he was the K.T. Li Professor of Global Health at the Harvard T.H. Chan School of Public Health and Director of the Harvard Global Health Institute.  An internationally respected and consulted pandemic expert, Jha strongly believes that communication with the public is an essential part of public health, and never more important than during a public-health emergency like COVID-19.  He appears regularly on national news network shows, is active on social media, and is the authoritative voice on the “COVID: What Comes Next” podcast, available from The Providence Journal and the USA TODAY Network.  In addition to his duties at Brown, maintains a clinical practice at the Providence VA Medical Center. See omnystudio.com/listener for privacy information.

Informal talks continue at the World Trade Organisation on whether to waive Covid-19 vaccine patents, as developing countries call for more equity in the vaccines' distribution. Dr. Ingrid Katz of the Harvard Global Health Institute explains why waiving patents could help save more lives in the developing world, and also aid the global economy. But Arthur Appleton professor of International Law and partner with trade law firm Appleton Luff, says we should expect significant legal challenges to such a liberalisation. Also in the programme, the European Commission vice-president Margaritis Schinas will outline a new vision for the EU's Schengen area. Koert Debeuf of the EU Observer sets out the challenges the area will face in the future. And we'll conclude this edition with a view from economist Michael Hughes about the recovery on stock markets around the world, and Jeff Collins, chief economist of business services platform Coupa talks about the recovery they are seeing in their e-commerce data.

Greetings Glocal Citizens! This week my guest is a social entrepreneur that is on the cutting edge of solving for some of our most pressing global challenges. In this timely conversation I meet with Jaykumar Menon, an international human rights lawyer plying his craft at the intersection of human rights and global health. He is a founder of the Open Source Pharma Foundation (https://www.opensourcepharma.net/), which aims to create a new paradigm for drug discovery, and generate affordable new cures in areas of great health need. He is also a founder of The India Nutrition Initiative, which is developing “DFS”, a salt that is double-fortified with iron and iodine, to address malnutrition caused by iron deficiency. DFS has reached millions of people. In his work as a lawyer, he has represented the student leaders of Tiananmen Square, victims of the Bosnian genocide, freed a man from death row, and helped free an innocent man serving life for murder as the fifteenth lawyer to take up the case. He is a recipient of the Brown Alumni Association’s highest honor, given to one graduate per year. A Visiting Scientist at the Harvard School of Public Health, a Senior Fellow at the Harvard Global Health Institute, and a Research Fellow at the Centre for International Sustainable Development Law at McGill University. Jaykumar holds a JD and a Master of International Affairs from Columbia University and a BA from Brown University. I am sure this discussion will be plenty of food for thought and practice; I encourage you to read on, visit and get involved with this pioneering work! Where to find Jaykumar: www.ospfound.org (https://www.ospfound.org/) On LinkedIn (https://www.linkedin.com/in/jaykumar-menon-5709a/) On Twitter (https://twitter.com/jaykumar_menon?lang=en) On Facbook (https://www.facebook.com/opensourcepharma/) What's Jaykumar reading? The Stoics (https://www.theschooloflife.com/thebookoflife/the-great-philosophers-the-stoics/) and Marcus Aurelius (https://en.wikipedia.org/wiki/Marcus_Aurelius) Joan Dideon (https://en.wikipedia.org/wiki/Joan_Didion) Ernest Hemingway (https://en.wikipedia.org/wiki/Ernest_Hemingway) Sherwood Anderson (https://en.wikipedia.org/wiki/Sherwood_Anderson) Tom Wolfe (https://en.wikipedia.org/wiki/Tom_Wolfe) Bruce Chatwin (https://en.wikipedia.org/wiki/Bruce_Chatwin) Arundhati Roy (https://www.amazon.com/Arundhati-Roy/e/B000AP7ZT4) Other topics of interest: XPRIZE Foundation (https://www.xprize.org/) Dr. Robert Gallo (https://en.wikipedia.org/wiki/Robert_Gallo) March of Dimes (https://www.marchofdimes.org/mission/who-we-are.aspx) University of Trans-Disciplinary Health Sciences and Technology (https://tdu.edu.in/) The Institute of Ayurveda and Integrative Medicine (I-AIM) (https://www.iaimhealthcare.org/) 8 Limbs of Yoga (https://liforme.com/blogs/blog/8-limbs-yoga-explained) The Five Tibetan Rites (https://en.wikipedia.org/wiki/Five_Tibetan_Rites) Special Guest: Jaykumar Menon.

In this event, Mr Sands discusses how to enhance Global Health Preparedness for the Future. He highlights the impact of the disruption by the COVID-19 pandemic on the treatment of other infectious diseases such as HIV/AIDS, tuberculosis and malaria and the substantial set-back it poses to recent progress in public health systems in Africa and elsewhere, particularly in this decade of action for the UN Sustainable Development Goals. He also explores methods to counter this impact and to be better prepared for the future. This is the second event in the 2021 Development Matters lecture series, co-organised by the IIEA and Irish Aid. About the Speakers: Peter Sands has been the Executive Director of The Global Fund to Fight AIDS, Tuberculosis and Malaria since March 2018. Since June 2015, Mr Sands has been a Research Fellow at Harvard University, dividing his time between the Mossavar-Rahmani Center for Business and Government at Harvard Kennedy School and the Harvard Global Health Institute. Mr Sands was Group CEO of Standard Chartered PLC from November 2006 to June 2015, having joined the board as Group CFO in May 2002. Prior to this, Mr Sands was a Senior Partner at McKinsey & Co. Mr Sands has served on various boards and commissions, including the UK's Department of Health, the World Economic Forum and the International Advisory Board of the Monetary Authority of Singapore.

Dr. Ingrid Katz is the associate faculty director at the Harvard Global Health Institute and an associate professor at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. I.T. Katz and Others. From Vaccine Nationalism to Vaccine Equity — Finding a Path Forward. N Engl J Med 2021;384:1281-1283.

A practicing physician, Ashish K. Jha,  M.D., MPH, is recognized globally as an expert on pandemic preparedness and response as well as on health policy research and practice. He joined to the Brown School of Public Health as Dean fter leading the Harvard Global Health Institute and teaching at the Harvard T.H. Chan School of Public Health and Harvard Medical School. Dr. Jha has published more than two hundred original research publications in prestigious journals such as the New England Journal of Medicine and the BMJ, and is a frequent contributor to a range of public media. He has extensively researched how to improve the quality and reduce the cost of health care, focusing on the impact of public health policy nationally and around the globe. Before joining the Brown School of Public Health, Dr. Jha was a faculty member at the Harvard T.H. Chan School of Public Health (HSPH) since 2004 and Harvard Medical School since 2005. He was the Faculty Director of the Harvard Global Health Institute from 2014 until September 2020. From 2018 to 2020, he served as the Dean for Global Strategy at the Harvard T.H. Chan School of Public Health. A general internist previously with the West Roxbury VA in Massachusettts, he practicea at the Providence VA Medical Center.  Ashish was elected to the National Academy of Medicine in 2013. Follow him on twitter @ashishkjha Miriam Laufer MD is the Assistant Dean for Student Research and Education at University of Maryland School of Medicine Dr. Laufer is a pediatric infectious disease specialist, with a primary research interest in malaria and global child health. She has conducted research, clinical care and professional education in resource-limited countries in Africa and Asia, and has dedicated nearly two decades to working in Malawi. She and her research team use clinical and laboratory research to develop and evaluate interventions to decrease the burden of malaria in sub-Saharan Africa. She currently serves as Principal Investigator for clinical trials, epidemiological studies and a Fogarty training grant, that support her collaboration with colleagues throughout the US, Europe and Africa. In 2006, she published her first author paper Return of Chloroquine Antimalarial Efficacy in Malawi in the New England Journal of Medicine Dr. Laufer directs the Malaria Research Program at the Center for Vaccine Development and Global Health. ‌‌The Malaria Research Program aims to support global malaria eradication efforts by developing and deploying innovative tools for improved malaria treatment, prevention and surveillance. Recognizing that progress requires interdisciplinary and international partnerships now and in the future, we work in collaboration with researchers across the globe and focus on training young scientists and clinical investigators to build research capacity both in the US and in malaria-endemic countries. Follow her on twitter @MirLaufer

The benefits of the Mediterranean diet pass on to the families of patients who follow it Hospital del Mar Medical Research Institute (Italy), March 9, 2021 People living with a patient undergoing an intensive weight loss treatment also benefit from this therapy. This has been demonstrated by a team of researchers from the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) along with doctors from Hospital del Mar and the CIBER on the Physiopathology of Obesity and Nutrition (CIBERObn), in collaboration with IDIAPJGol, the Pere Virgili Health Research Institute (IISPV), IDIBELL, IDIBAPS and the Sant Joan de Reus University Hospital. The study has been published in the journal International Journal of Obesity. The study analysed data from 148 family members of patients included in the weight loss and lifestyle programme PREDIMED-Plus (PREVencióDIetaMEDiterranea Plus) over a two-year period. The researchers analysed whether these people also indirectly benefited from the programme, as they were not enrolled in the study and did not receive any direct treatment. PREDIMED-Plus is a multicentre study in which a group of patients follow an intensive weight reduction programme based on the Mediterranean diet and a plan promoting physical activity. Weight loss despite not being included in the programme The relatives (three out of four were the patient's partner and the rest were children, parents, siblings or had some other degree of kinship), lost an average of 1.25 kg of weight during the first year of the programme, compared to the relatives of the patients in the control group (those who did not follow the intensive treatment proposed by PREDIMED-Plus). This rose to almost 4 kg in the second year. These figures were better in cases where the family member ate with the patient and, above all, when it was the patient themselves who cooked. The treatment, aimed at achieving weight loss in people with obesity and high cardiovascular risk by following the Mediterranean diet, "Achieved effects beyond just weight loss in the patient, and this extended to their family environment", explains Dr. Albert Goday, the principal investigator on the project, head of section in the Department of Endocrinology and Nutrition at Hospital del Mar, researcher in the Cardiovascular Risk and Nutrition Research Group at the IMIM-Hospital del Mar and a CIBERobn researcher. "The effect was contagious, in this context it was, fortunately, a beneficial 'contagion', resulting in weight loss and improved dietary habits." Dr. Goday points out that "among the many possible dietary approaches to weight loss, the one based on the Mediterranean diet is the most easilt shared within a family environment." According to Dr. Olga Castañer, the final author of the study and a researcher in the Cardiovascular Risk and Nutrition Research Group at the IMIM-Hospital del Mar and CIBERobn, the good results can be explained "By an improved diet, since the same contagious effect was not observed in terms of physical activity among the patients and their relatives." Family members also showed increased commitment to the Mediterranean diet, according to a questionnaire assessing adherence to the dietary patterns of this regimen. But the same was not true in terms of physical activity. As Dr Castañer points out, "In addition to weight loss, there was greater adherence to the Mediterranean diet, which has intrinsic health benefits, such as protection against cardiovascular and neurodegenerative risks." The results of the study "Demonstrate the contagion effect, the halo effect, of a treatment programme in the relatives of participants involved in an intensive weight loss procedure, as well as increased adherence to the Mediterranean diet", stresses Dr. Albert Goday. "The beneficial effect of the programme on one member of the family unit can be extended to its other members, which is extremely significant in terms of reducing the burden of obesity on the public health system", he explains. The family members not only lost weight but also improved the quality of their diet. Effect of the programme on patients The study also analysed the results of the PREDIMED-Plus programme in 117 patients. Compared to participants in the control group, they lost 5.10 kg in the first year of intervention rising to 6.79 kg in the second year. They also significantly increased their physical activity levels, as well as their adherence to the Mediterranean diet.     CBD reduces plaque, improves cognition in model of familial Alzheimer's Medical College of Georgia at Augusta University, March 9, 2021 A two-week course of high doses of CBD helps restore the function of two proteins key to reducing the accumulation of beta-amyloid plaque, a hallmark of Alzheimer's disease, and improves cognition in an experimental model of early onset familial Alzheimer's, investigators report.  The proteins TREM2 and IL-33 are important to the ability of the brain's immune cells to literally consume dead cells and other debris like the beta-amyloid plaque that piles up in patients' brains, and levels of both are decreased in Alzheimer's.  The investigators report for the first time that CBD normalizes levels and function, improving cognition as it also reduces levels of the immune protein IL-6, which is associated with the high inflammation levels found in Alzheimer's, says Dr. Babak Baban, immunologist and associate dean for research in the Dental College of Georgia and the study's corresponding author.  There is a dire need for novel therapies to improve outcomes for patients with this condition, which is considered one of the fastest-growing health threats in the United States, DCG and Medical College of Georgia investigators write in the Journal of Alzheimer's Disease.  "Right now we have two classes of drugs to treat Alzheimer's," says Dr. John Morgan, neurologist and director of the Movement and Memory Disorder Programs in the MCG Department of Neurology. One class increases levels of the neurotransmitter acetylcholine, which also are decreased in Alzheimer's, and another works through the NMDA receptors involved in communication between neurons and important to memory. "But we have nothing that gets to the pathophysiology of the disease," says Morgan, a study coauthor.  The DCG and MCG investigators decided to look at CBD's ability to address some of the key brain systems that go awry in Alzheimer's.  They found CBD appears to normalize levels of IL-33, a protein whose highest expression in humans is normally in the brain, where it helps sound the alarm that there is an invader like the beta-amyloid accumulation. There is emerging evidence of its role as a regulatory protein as well, whose function of either turning up or down the immune response depends on the environment, Baban says. In Alzheimer's, that includes turning down inflammation and trying to restore balance to the immune system, he says. That up and down expression in health and disease could make IL-33 both a good biomarker and treatment target for disease, the investigators say.  CBD also improved expression of triggering receptor expressed on myeloid cells 2, or TREM2, which is found on the cell surface where it combines with another protein to transmit signals that activate cells, including immune cells. In the brain, its expression is on the microglial cells, a special population of immune cells found only in the brain where they are key to eliminating invaders like a virus and irrevocably damaged neurons. Low levels of TREM2 and rare variations in TREM2 are associated with Alzheimer's, and in their mouse model TREM2 and IL-33 were both low.  Both are essential to a natural, ongoing housekeeping process in the brain called phagocytosis, in which microglial cells regularly consume beta amyloid, which is regularly produced in the brain, the result of the breakdown of amyloid-beta precursor protein, which is important to the synapses, or connection points, between neurons, and which the plaque interrupts.  They found CBD treatment increased levels of IL-33 and TREM2 -- sevenfold and tenfold respectively.  CBD's impact on brain function in the mouse model of early onset Alzheimer's was assessed by methods like the ability to differentiate between a familiar item and a new one, as well as observing the rodents' movement.  People with Alzheimer's may experience movement problems like stiffness and an impaired gait, says Dr. Hesam Khodadadi, a graduate student working in Baban's lab. Mice with the disease run in an endless tight circle, behavior which stopped with CBD treatment, says Khodadadi, the study's first author.  Next steps include determining optimal doses and giving CBD earlier in the disease process. The compound was given in the late stages for the published study, and now the investigators are using it at the first signs of cognitive decline, Khodadadi says. They also are exploring delivery systems including the use of an inhaler that should help deliver the CBD more directly to the brain. For the published studies, CBD was put into the belly of the mice every other day for two weeks. A company has developed both animal and human inhalers for the investigators who also have been exploring CBD's effect on adult respiratory distress syndrome, or ARDS, a buildup of fluid in the lungs that is a major and deadly complication of COVID-19, as well as other serious illnesses like sepsis and major trauma. The CBD doses used for the Alzheimer's study were the same the investigators successfully used to reduce the "cytokine storm" of ARDS, which can irrevocably damage the lungs.  Familial disease is an inherited version of Alzheimer's in which symptoms typically surface in the 30s and 40s and occurs in about 10-15% of patients.  CBD should be at least equally effective in the more common, nonfamilial type Alzheimer's, which likely have more targets for CBD, Baban notes. They already are looking at its potential in a model of this more common type and moving forward to establish a clinical trial.  Plaques as well as neurofibrillary tangles, a collection of the protein tau inside neurons, are the main components of Alzheimer's, Morgan says. Beta-amyloid generally appears in the brain 15-20 years or more before dementia, he says, and the appearance of tau tangles, which can occur up to 10 years afterward, correlates with the onset of dementia. There is some interplay between beta amyloid and tau that decrease the dysfunction of each, Morgan notes.  The Food and Drug Administration is scheduled to make a ruling by early June on a new drug aducanumab, which would be the first to attack and help clear beta amyloid, Morgan says.     1,25-dihydroxyvitamin D supports bone marrow stem cell proliferation Cang-zhou Central Hospital (China), March 1, 2021 According to news originating from Hebei, People’s Republic of China, research stated, “Osteoporosis (OP) is a common clinical geriatric disease. Bone marrow mesenchymal stem cells (BMSCs) are widely applied in bone engineering. 1,25-dihydroxyvitamin D (1,25-(OH) 2D) deficiency involves in geriatric disease.” Our news journalists obtained a quote from the research from Cangzhou Central Hospital, “However, its effects on BMSCs differentiation and osteoporosis have not yet been elucidated. An OVX-induced OP rat model was constructed and treated with 10 mu M 1,25-(OH) 2D followed by analysis of bone mineral density and ALP activity. Rat BMSCs were isolated and divided into control group, OP group, OP rat BMSCs, and VD group (OP rats were injected with 1 mu M 1,25-(OH) 2D) followed by analysis of cell survival by MTT assay, Caspase 3 activity, type I collagen and Osterix expression by Real time PCR, Wnt5 expression by Western blot and TGF-beta secretion by ELISA. The bone density and ALP activity was significantly decreased in OP rats (P < 0.05). 1,25 (OH) 20 injected into OP rats significantly increased bone density and ALP activity (P < 0.05). The survival rate of BMSCs in OP group was significantly decreased and Caspase 3 activity was increased along with downregulated type I collagen and Osterix, TGF-beta secretion and Wnt5 expression (P < 0.05).” According to the news editors, the research concluded: “Adding 1,25-(OH) 2D to BMSCs cells in OP group could significantly reverse the above changes (P < 0.05). 1,25-dihydroxyvitamin D promotes BMSCs proliferation by regulating Wnt5/TGF-beta signaling, promotes differentiation into osteogenesis, increases bone density, and then improves osteoporosis.” This research has been peer-reviewed.     High-fat diets can cause normal liver tissue to behave like tumor tissue Flanders Institute of Biotechnology (Belgium), March 10, 2021 Normal, non-cancerous liver tissue can act like tumor tissue when exposed to a diet high in fat, linking diet and obesity to the development of liver cancer. The Laboratory of Cellular Metabolism and Metabolic Regulation headed by Prof. Sarah-Maria Fendt (VIB-KU Leuven Center for Cancer Biology), shows how the livers of mice on a high-fat diet used glucose in a way similar to aggressive cancer cells. This suggests that when the liver is exposed to excess fat, normal tissue could be primed to become cancerous. The study appeared in the journal Cancer Research. Cancer and obesity With global rates of obesity and liver cancerincreasing each year, understanding how excess fat availability can drive liver cancerdevelopment is important to understand how the disease starts and how it can be treated. To explore this, Prof. Fendt and her team tested the metabolic changes in liver tissue from mice fed a high-fat diet at an early time point when no tumors were present, and late time point when tumors had formed. They found that before there were any clues that cancer was developing, the liver tissue used glucose the same way that tumors would. This high use of glucose is one of the well-known hallmarks of cancer and is known as the Warburg effect. After finding these early changes to liver tissue, they investigated what happens when tumors have fully formed. One way they measured this was to test sensitivity to glucose, which is usually cleared away quickly by the body but is impaired in obesity-induced diabetic animals. Prof. Fendt describes what they found: "Strikingly, mice fed a high-fat diet who had a large tumor burden could remove glucose from their blood as easily as healthy mice despite being diabetic. Using state-of-the-art 13C6-glucose tracing technology, we could observe how glucose molecules are used in cells and tissues, and we found that that tumor tissue breaks down glucose in a consistent way, regardless of whether the mice were fed high-fat or normal diets." Alternative pathways These findings suggest that when cancer cells develop from normal liver cells, their metabolism consistently increases glucose use. Since a high-fat diet causes these changes before cancer is present, this may mean that—in a high-fat diet—non-cancer liver tissue could be more likely to become cancerous. The team also looked into deeper mechanisms for this effect. Dr. Lindsay Broadfield, one of the lead authors of the study, says: "We discovered that, before any cancer development, liver tissue exposed to high fat seemed to use an alternative pathway for fat breakdown in a cellular compartment called the peroxisome. Using cancer liver cells, we then confirmed that peroxisome metabolism increased cellular stress and glucose uptake." Fat can be used by cells in several ways—for energy, to stimulate growth pathways, or to be stored for later use. The scientists used the Lipometrix lipidomics platform at KU Leuven to see if there was anything unique about the fate of fat in tumor cells and found that the fat species and content in tumor cells were indeed different from non-cancerous liver tissue close to the tumors.     For teens, outdoor recreation during the pandemic linked to improved well-being North Carolina State University, March 9, 2021 A study from North Carolina State University found outdoor play and nature-based activities helped buffer some of the negative mental health impacts of the COVID-19 pandemic for adolescents.  Researchers said the findings, published in the International Journal of Environmental Research and Public Health, point to outdoor play and nature-based activities as a tool to help teenagers cope with major stressors like the COVID-19 pandemic, as well as future natural disasters and other global stressors. Researchers also underscore the mental health implications of restricting outdoor recreation opportunities for adolescents, and the need to increase access to the outdoors. "Families should be encouraged that building patterns in outdoor recreation can give kids tools to weather the storms to come," said Kathryn Stevenson, a study co-author and assistant professor of parks, recreation and tourism management at NC State. "Things happen in life, and getting kids outside regularly is an easy way to build some mental resilience." In the survey, conducted from April 30 to June 15, 2020, researchers asked 624 adolescents between the ages of 10 to 18 years to report their participation in outdoor recreation both before the pandemic and after social distancing measures were in effect across the United States. They also asked adolescents about their subjective well-being, a measure of happiness, and mental health. The findings revealed the pandemic had an impact on the well-being of many teens in the survey, with nearly 52 percent of adolescents reporting declines in subjective well-being. They also saw declines in teens' ability to get outside, with 64 percent of adolescents reporting their outdoor activity participation fell during the early months of the pandemic. Despite these declines in outdoor activity participation, nearly 77 percent of teens surveyed believed that spending time outside helped them deal with stress associated with the COVID-19 pandemic. "We know that a lot of outdoor activities that kids engage in happen during school, in youth sports leagues or clubs, and those things got put on hold during the pandemic," said the study's lead author Brent Jackson, a graduate student in the Fisheries, Wildlife and Conservation Biology Program at NC State. "Based on our study, they were getting outside less - we think not being in school and having those activities really contributed to that." When they broke down recreation by type, they saw participation in outdoor play activities such as sports, biking, going for walks, runs or skating declined by 41.6 percent, nature-based activities such as camping, hiking, fishing, hunting, and paddling dropped by 39.7 percent, and outdoor family activities declined by 28.6 percent. In those early months of the pandemic, about 60 percent of teens said they were able to get outside once a week or less. "We saw declines in all three types of outdoor recreation participation," Jackson said. "Nature-based activities had the lowest participation before and during the pandemic, which may point to the need for more access to natural spaces in general." Results showed that well-being and outdoor recreation trends were linked, and the negative trends they saw during the pandemic for well-being and participation in outdoor recreation were seen regardless of teens' race, gender, age, income community type or geographic region. Kids who did not get outside as much saw declines in well-being, but those who got outside both before and during the pandemic were able to maintain higher levels of well-being.  "This tells us that outdoor recreation can promote well-being for kids when it happens, and can potentially take away from well-being when it doesn't," Stevenson said. Teens who had high rates of outdoor play before the pandemic were more resistant to negative changes in social well-being. Those who got outside frequently before the pandemic were more likely to experience a lesser decline in well-being, regardless of participation during the pandemic. And, for teens who were able to play outside or get involved in nature-based activities during the pandemic, their well-being was on par with pre-pandemic levels. "Kids who were able to continue participating in outdoor play and nature-based activities had subjective well-being levels that were similar to what they were before the pandemic, but kids who weren't able to participate saw much greater declines," Jackson said. The study's findings also point to strategies to help kids navigate future global stressor events, as well as the importance of ensuring access to outdoor recreation. They help define the risks associated with policies that reduce kids' ability get outside. "Going outside and participating in activities that provide exposure to nature, physical activity and safe social interaction during the pandemic were really powerful in terms of improving kids' resilience," Jackson said.     Study finds two servings of fish per week can help prevent recurrent heart disease McMaster University (Ontario), March 8, 2021 An analysis of several large studies involving participants from more than 60 countries, spearheaded by researchers from McMaster University, has found that eating oily fish regularly can help prevent cardiovascular disease (CVD) in high-risk individuals, such as those who already have heart disease or stroke. The critical ingredient is omega-3 fatty acids, which researchers found was associated with a lower risk of major CVD events such as heart attacks and strokes by about a sixth in high-risk people who ate two servings of fish rich in omega-3 each week. "There is a significant protective benefit of fish consumption in people with cardiovascular disease," said lead co-author Andrew Mente, associate professor of research methods, evidence, and impact at McMaster and a principal investigator at the Population Health Research Institute.  No benefit was observed with consumption of fish in those without heart disease or stroke. "This study has important implications for guidelines on fish intake globally. It indicates that increasing fish consumption and particularly oily fish in vascular patients may produce a modest cardiovascular benefit."  Mente said people at low risk for cardiovascular disease can still enjoy modest protection from CVD by eating fish rich in omega-3, but the health benefits were less pronounced than those high-risk individuals.  The study was published in JAMA Internal Medicine on March 8.  The findings were based on data from nearly 192,000 people in four studies, including about 52,000 with CVD, and is the only study conducted on all five continents. Previous studies focused mainly on North America, Europe, China and Japan, with little information from other regions. "This is by far the most diverse study of fish intake and health outcomes in the world and the only one with sufficient numbers with representation from high, middle and low income countries from all inhabited continents of the world," said study co-lead Dr. Salim Yusuf, professor of medicine at the Michael G. DeGroote School of Medicine and executive director of the PHRI.  This analysis is based in data from several studies conducted by the PHRI over the last 25 years. These studies were funded by the Canadian Institutes for Health Research, several different pharmaceutical companies, charities, the Population Health Research Institute and the Hamilton Health Sciences Research Institute.     COVID-19 or something else? Learn how COVID-19 symptoms compare to other illnesses, and when you should call the doctor. Harvard University, March 10, 2021   Before 2020, you might not have worried much about a tickle in your throat or a little tightness in your chest. But that's changed. Now even slight signs of a respiratory bug might make you wonder if it's the start of COVID-19, the illness that has become a pandemic. How do you distinguish one illness from another? It's complicated. "Many of the symptoms overlap. For example, it's very hard for me clinically, as a physician, to be able to look at someone and say it's COVID-19 or it's influenza," says Dr. Ashish Jha, former director of the Harvard Global Health Institute and now dean of the Brown University School of Public Health. Don't jump to conclusions if you start to feel sick. Learn the hallmarks of common illnesses and how they differ from COVID-19, so you can take the appropriate action. COVID-19 COVID-19 is an extremely contagious respiratory illness caused by a type of virus (a coronavirus) called SARS-CoV-2. It's a cousin of the common cold, but its potential consequences are far more serious: hospitalization, lasting complications, and death. Hallmarks: Loss of taste and smell (in the absence of nasal congestion), fever, cough, shortness of breath, and muscle aches. Other potential symptoms: Sore throat, diarrhea, congestion, runny nose, chills, shivering, headache, fatigue, and loss of appetite. Note: Some infected people don't have any symptoms of COVID-19, but they're still contagious. Influenza Influenza (flu) is a highly contagious respiratory infection caused by the influenza A, B, or C virus. The U.S. flu season typically lasts from October to March, but flu is present year-round. Hallmarks: Fever, muscle aches, and cough. Other potential symptoms: Sore throat, diarrhea, congestion, runny nose, chills, shivering, headache, fatigue, loss of appetite. Different from COVID-19: Flu usually does not cause shortness of breath. Common cold The common cold (viral rhinitis) is an upper respiratory infection that can be caused by any of hundreds of different viruses (including coronaviruses or rhinoviruses). It's usually mild and resolves within a week. Hallmarks: Congestion, runny nose, cough, and sore throat. Other potential symptoms: Fever, muscle aches, and fatigue. Different from COVID-19: A cold does not cause shortness of breath, body aches, chills, or loss of appetite, and it usually doesn't cause fever. Seasonal allergies A seasonal allergy isn't a virus; it's caused when the immune system responds to a harmless non-human substance, like tree pollen, as if it were a dangerous threat. Allergies are typically seasonal, lasting for weeks or months, depending on the allergen in the air (mold is the common allergen in the fall and winter). Hallmarks: Runny nose, itchy eyes, sneezing, congestion. Other potential symptoms: Loss of smell from congestion. Different from COVID-19: Allergies do not cause fevers, coughing, shortness of breath, muscle aches, sore throat, diarrhea, chills, headaches, fatigue, or loss of appetite. Asthma Asthma is a chronic lung condition caused by inflammation in the air passages. Airways narrow and make it harder to breathe, which can cause concern that it might be COVID-19. "Asthma can be triggered by a cold or influenza, but it's a separate condition," Dr. Jha says. Hallmarks: Wheezing (a whistling sound as air is forcibly expelled), difficulty breathing, chest tightness, and a persistent cough. Other potential symptoms: A severe asthma attack can cause sudden, extreme shortness of breath; chest tightness; a rapid pulse; sweating; and bluish discoloration of the lips and fingernails. Different from COVID-19: Asthma does not cause a fever, muscle aches, sore throat, diarrhea, congestion, loss of taste or smell, runny nose, chills, shivering, headache, fatigue, or loss of appetite.

Dr. Ingrid Katz is an Associate Director at the Harvard Global Health Institute, Associate Physician in the Department of Medicine at Brigham and Women's Hospital, Assistant Professor in Medicine at Harvard Medical School, and a research scientist at the Center for Global Health at Massachusetts General Hospital. Ingrid's research focuses on the social determinants of health-seeking behavior among people living with HIV in South Africa. Ingrid talks with Valerie and Carly about biking across the country after college to raise awareness about HIV, her interest in the “complexity of the human condition”, the value of interdisciplinary teams, her many work hats (doctor, scientist, teacher), and being part of the first openly gay couple to match at a Harvard-affiliated hospital. Read more about Dr. Katz's work here: https://globalhealth.harvard.edu/team/ingrid-katz/Follow her on Twitter: @IngridKatzMDAccess recordings from Dr. Katz's class (Confronting COVID-19: Science, History, Policy) here: https://globalhealth.harvard.edu/domains/pandemics/courses/Watch Dr. Katz chat with the Time for Kids reporters about COVID-19 here: https://www.timeforkids.com/g56/ask-the-expert-katz/

Press conference from the Harvard School of Public Health with Thomas Tsai, assistant professor in the Department of Health Policy and Management and a faculty member in the Harvard Global Health Institute. This call was recorded at 11 a.m. Eastern Time on Thursday, December 3rd.

According to the Harvard Global Health Institute, Healthcare accounts for nearly 10% of all U.S. greenhouse gas emissions. Listen to Ben Winfield, H&LS Social Value and Decarbonization lead from Atos on how healthcare and life science organizations can use technology and careful planning to reduce carbon emissions and gases.

Press conference from the Harvard School of Public Health with Thomas Tsai, assistant professor in the Department of Health Policy and Management and a faculty member in the Harvard Global Health Institute. This call was recorded at 12:00 p.m. Eastern Time on Thursday, November 5th.

A new website from the Halloween and Costume Association provides a list of socially-distant ideas and an interactive map, using data from the Harvard Global Health Institute, which breaks down COVID-19 risk-level by county. Dr. Thomas Tsai, assistant professor of Health Policy and Management at the Harvard School of Public Health, and Kevin Johnson, chairman of the Halloween And Costume Association board, join the program to tell us more about the initiative.Plus, Netherworld’s co-founder, Ben Armstrong, talks about how his staff is adapting to the COVID-19 pandemic.

As Election Day finally hits America, so does the pandemic. Voter turnout is soaring--and so are COVID cases. It’s the scariest Halloween in recent history. But we’ve got no tricks in this episode--it’s all treats. We’ve got useful, thoughtful, candid analysis and recommendations from one of the brightest public health minds in America.  Dr. Vin Gupta (@VinGuptaMD) [10:05] is a helper and a patriot. He’s the guy you wish was your personal doctor right now. He’s a public health physician, an Air Force officer, a professor, an NBC News analyst, and true voice of reason. Since the pandemic hit, Dr. Gupta has emerged as a true superstar that Americans of all backgrounds respect and trust. He’s young, brilliant and working every day on the front lines of the pandemic on a range of critical fronts from seeing patients, to appearing on national TV, to guiding tech giant Amazon.  Dr Gupta has spent 15 years working worldwide to improve public health for organizations including the US Centers for Disease Control, the Institute for Health Metrics and Evaluation, the Harvard Global Health Institute, the World Health Organization, and the Pentagon’s Center for Global Health Engagement. He’s also a Major in the United States Air Force Reserve Medical Corps, where he serves as a critical care aerospace physician with the 446th Aeromedical Staging Squadron based at Joint-Base Lewis McChord. Gupta has assisted with bolstering the emergency health crisis response capabilities of partner nations in Africa as part of the US State Department’s African Peacekeeping Rapid Response Partnership initiative. He’s also the Principal Scientist at Amazon, where he provides clinical and strategic leadership to the company’s COVID-19 response work. Dr. Vin Gupta joins our host, Army veteran, activist and author, Paul Rieckhoff (@PaulRieckhoff) for a must-hear conversation that will leave you better informed and ready for what comes after the election—no matter who wins.  In these trying times especially, Angry Americans is your trusted place for independent news, politics and inspiration. We deliver a unique, independent and hard-hitting perspective like nowhere else in media. You’ll hear influential, fascinating guests like Dr Vin Gupta in ways you won’t on any other show. And Rieckhoff breaks down our crazy times like nobody else.  If you’re not angry, you’re not paying attention. Especially now. Join our Angry Americans Patreon community and get special access to our host, our dynamic guests, discounts on merch, and exclusive content not available anywhere else. This episode is possible thanks to those Patreon members and support from Uncle Nearest Premium Whiskey.  Join the movement at AngryAmericans.us or our YouTube page. You can watch this entire conversation with Dr. Vin Gupta and a range of foreign policy and national security leaders like Malcolm Nance, General Mark Hertling, Ambassador Susan Rice, Medal of Honor Recipients David Bellavia and Florent Groberg. And, a refreshing diversity of voices ranging from Stephen Colbert to Jeffrey Wright to Meghan McCain.  Angry Americans empowers truly independent Americans and is powered by Righteous Media.  Twitter: https://twitter.com/AngryAmericans Facebook: https://www.facebook.com/angryamericansus Instagram: http://instagram.com/angryamericansUSA And YouTube: https://www.youtube.com/channel/UCrlrGIJcmgIsJQgOR1ev-ew/featured Learn more about your ad choices. Visit megaphone.fm/adchoices

BIO IQ UPENDING TESTING INDUSTRY AMID COVID-19 Modernizing Testing to Keep Workforces and Communities Safe. The U.S. isn’t doing enough testing to control COVID-19. according to researchers at Harvard Global Health Institute who say we need 4.4 million tests per day to reach “a basic level of proactive testing,” and far more (14M) is necessary to safely reopen the economy. […] The post TMBS E120: Sean Flovenski BIO IQ Testing & COVID-19 appeared first on Business RadioX ®.

Whatever the final count of fatalities is in the United States from the COVID-19 pandemic, the cost is already far too high.  Dr. Ashish Jha reminds us that there are still simple things that Americans can do to stay safe, to stay healthy, and to help fight the pandemic. Jha is a practicing physician and is the Dean of the Brown School of Public Health and professor of Health Services, Policy, and Practice after serving as the director of the Harvard Global Health Institute and teaching at the Harvard School of Public Health and Harvard Medical School.  He has been recognized as a global expert on pandemic preparedness and response in addition to health policy research and practice.  He has led groundbreaking research around Ebola and is now on the frontlines of the COVID-19 response, leading national and international analysis of key issues and advising state and federal policy makers. Jha has published more than two hundred original research publications in prestigious journals including the BMJ and New England Journal of Medicine and is a frequent contributor to a range of public media. He has conducted extensive research on improving the quality of health care and the reduction of its costs, focusing on the impact of public health policy both nationally and globally. See omnystudio.com/listener for privacy information.

This is Coronavirus 411, the latest COVID-19 info and new hotspots… Just the facts… for September 21st, 2020. More than a month ago, Russia became the first country to approve a vaccine. But health officials and outside experts say that country has yet to administer it to a large population outside a clinical trial. Approval occurred before Russia tested the vaccine in late-stage trials. The number of states regarded as “at a tipping point” for infections has jumped from one to six in the past week. The Harvard Global Health Institute and Brown School of Public Health show that North Dakota, Wisconsin, South Dakota, Arkansas, Missouri and Oklahoma should be under stay-at-home orders.Iowa Governor Kim Reynolds has been saying school districts should hold at least half of classes in-person. In Des Moines, they’re saying no. The school board voted again last week to violate Reynolds’ order.Representative Jahana Hayes, a Democrat from Connecticut, is the latest Congressperson to test positive. She’ll quarantine 14 days. More than a dozen representatives and two senators have tested positive for the virus over the course of the pandemic. Parts of Madrid, not happy about the return of lockdowns. Residents, mostly in the working-class suburbs, took to the streets in protest. The latest lockdown will affect about 850,000 residents. The top 10 counties with the highest number of recent cases per capita according to The New York Times: Emmons, ND jumps to number one. Craig, OK. Rosebud, MT. Lincoln, AR. East Feliciana, LA. All new on the list, Concho, TX; Tripp, SD; Gregory SD; and Benson, ND. Stewart, GA rounds out the top 10.There are 2,550,510 active cases in the United States. The current Top 10 states by number of active cases: Florida, California, Georgia, Arizona, Virginia, Maryland, Missouri, Texas, Alabama, and South Carolina. The five states with the most daily new cases per capita over 7 days are North Dakota, Wisconsin, South Dakota, Arkansas and Missouri. The retransmission rate is currently fastest in New Hampshire, Rhode Island, Wisconsin, Utah and Wyoming. While the lowest retransmission is found in Hawaii, Texas, Mississippi, Louisiana, and California. There’ve been a total 199,474 deaths in the US reported as COVID-related, with a current national fatality rate of 2.98%.The states with the most new deaths reported as COVID-related: Texas 34. California 31. Louisiana 26. Virginia 25. Pennsylvania 21. Missouri 17. Massachusetts 15. Illinois and Ohio 14. And Florida and South Carolina with 11. Globally, there are 7,442,102 active cases.There are 299,345 new cases around the world in the last 24 hours, against a high of 312,135 on September 11th. The five countries with the most new cases: India 87,382. United States 33,344. Brazil 16,282. France 10,569. Argentina 8,431. There have been 958,637 deaths worldwide. Flat over 14 days. For the latest updates, subscribe for free to Coronavirus 411 on your podcast app or ask your smart speaker to play the Coronavirus 411 podcast. See acast.com/privacy for privacy and opt-out information.

Dr Reality discusses "Harvard Global Health Institute" and the "Edmond J. Safra Center for Ethics" wanting 13 states to initiate new lockdowns in late July (2020). Not one of the 13 states adhered to Harvard's demand. Using data graphs Dave shows you what happened in the 13 states that ignored Harvard. What will happen when [...]

Gym rats, rejoice? In a much-anticipated announcement, Gov. Gretchen Whitmer says gyms and fitness facilities can now officially reopen, if they require everyone to wear face masks. So, yay? Speaking of Big Gretch, one fellow Democrat who isn’t likely to end up on her Christmas card list this year is Mark Hackel, the Macomb County executive. Crain’s reports he’s backing “Unlock Michigan,” the petition drive aimed at stripping the guv of her powers to declare a statewide emergency, a la the stay-at-home order and other orders keeping certain classes of businesses closed. Macomb County is the only county listed as having accelerated spread over the last seven days in the tri-county or 10-county southeast Michigan region, according to globalepidemics.org from the Harvard Global Health Institute. In other news, we discuss the new Jeep Grand Wagoneer three-row SUV revealed on Thursday. (tl;dr version: IT’S BIG.) Quicken Loans made eleventy-bajillion dollars in its first quarterly earnings report to Wall Street since going public. The Detroit Police Department has unfurled a slew of new guidelines addressing the use of force, a hot topic during this horrible, nightmarish year, with a new phone number to report feedback and complaints about police encounters: 313-596-2499. Finally, I interview Danielle Todd, from Make Food Not Waste, about this month’s series of virtual events with local chefs exploring the issue of how to avoid food waste. Thanks for listening to Daily Detroit. If you like what you’re hearing, tell a friend about us, leave us a review and subscribe on Apple Podcasts, or support us by becoming a Patreon member.

Recorded August 24th, 2020. Our guest today is Dr. Ashish Jha, the K.T. Li Professor of Global Health at the Harvard T.H. Chan School of Public Health and Director of the Harvard Global Health Institute (HGHI), to discuss issues around schools reopening and then also discuss the topics of viral spread and what we currently know about immunity to COVID-19. Your host is Dr. Ted O’Connell, family physician, educator, and author of numerous textbooks and peer-reviewed articles. He holds academic appointments at UCSF, UC Davis, and Drexel University's medical schools and also founded the Kaiser Permanente Napa-Solano Community Medicine and Global Health Fellowship, the first program in the U.S. to formally combine both community medicine and global health. Follow Ted on Instagram (@tedoconnellmd) and Twitter (@tedoconnell)!  Dr. Ashish Jha is the K.T. Li Professor of Global Health at the Harvard T.H. Chan School of Public Health and Director of the Harvard Global Health Institute (HGHI). He is a practicing General Internist and is also Professor of Medicine at Harvard Medical School. Dr. Jha received his MD from Harvard Medical School and trained in Internal Medicine at the University of California in San Francisco. He completed his General Medicine fellowship at Brigham & Women’s Hospital and received his MPH from the Harvard T.H. Chan School of Public Health. Dr. Jha is a member of the Institute of Medicine at the National Academies of Sciences, Engineering, and Medicine. In September, Dr. Jha will begin work as the Dean of the Brown University School of Public Health.  Dr. Jha’s research focuses on improving the quality and costs of healthcare systems with a specialized focus on the impact of policies. He has published over two hundred papers in prestigious journals such as the New England Journal of Medicine, and the British Medical Journal, and heads a personal blog on using statistical data research to improve health quality. He has led groundbreaking research around Ebola and is now on the frontlines of the COVID-19 response. Dr. Jha leads national analysis of key issues around the COVID-19 pandemic, advising policy makers and elected officials at the state and federal level and appearing frequently on national television news outlets such as CNN, MSNBC, and Fox, and in written coverage from national newspapers including the New York Times and the Washington Post. Harvard Global Health Institute is providing critical analysis and data on national and state by state testing with Dr. Jha, a vocal advocate for increased testing and contact tracing who has written extensively on the subject. His work has appeared in the New England Journal of Medicine, Health Affairs, the Atlantic, the Wall Street Journal, and Stat News among others.  Links for this episode Twitter: @ashishkjha  Website: Harvard Global Health Institute LinkedIn: ashishjha Submit Your Questions for the Podcast Send an email to info@arslonga.media or check out covidpodcast.com What Can You Do? You can help spread commonsense about COVID-19 by supporting this podcast. Hit subscribe, leave a positive review, and share it with your friends especially on social media. We can each do our part to ensure that scientifically accurate information about the pandemic spreads faster than rumors or fears. Remember to be vigilant, but remain calm. For the most trusted and real time information on COVID-19 and the coronavirus pandemic, both the CDC and WHO have dedicated web pages to keep the public informed.  The information presented in this podcast is intended for educational purposes only and should not be construed as medical advice.  Producers: Christopher Breitigan. Executive Producer: Patrick C. Beeman, MD

Press conference from the Harvard T.H. Chan School of Public Health with Thomas Tsai, assistant professor in the Department of Health Policy and Management and an affiliated faculty member of the Harvard Global Health Institute. This call was recorded at 11:30 a.m. Eastern Time on Wednesday, August 19th.

Press conference from the Harvard T.H. Chan School of Public Health with Thomas Tsai, assistant professor in the Department of Health Policy and Management and an affiliated faculty member of the Harvard Global Health Institute. This call was recorded at 11:30 a.m. Eastern Time on Wednesday, August 19th.

As the President gears up for this week's Republican National Convention, his older sister Maryanne Trump Barry was secretly recorded calling her brother a liar with "no principles." Plus, a look back at last week's all-virtual Democratic Convention. And can the states handle a record number of Americans voting by mail in the November election? .On today's show: CNN's Kaitlan Collins and Toluse Olorunnipa of the Washington Post; Dr. Ashish Jha of the Harvard Global Health Institute and Dr. Megan Ranney of Brown University; Jonathon Martin of the New York Times and Laura Barron Lopez of POLITICO; Michigan Secretary of State Jocelyn Benson; Penn State professor Sarah Townsend.To learn more about how CNN protects listener privacy, visit cnn.com/privacy

Seven months into the pandemic, the case count remains high and testing is still a problem. Plus, President Trump admits to blocking funds for the U.S. Postal Service to hamstring mail-in voting efforts. And with the Democratic National Convention on the horizon, a historic VP pick helps boost Biden’s campaign. On today’s show: Dr. Ashish Jha of the Harvard Global Health Institute; Dr. Megan Ranney of Brown University and CNN’s Sanjay Gupta; Astead Herndon of the New York Times and Tarini Parti of the Wall Street Journal; Amber McReynolds of the National Vote at Home Institute and Jessica Huseman of ProPublica.To learn more about how CNN protects listener privacy, visit cnn.com/privacy

Expert on Pharmaceutical and Chemical-Related Technologies DR. DEAN L. FANELLI, Ph.D. So far, most of the conversation about COVID-19 vaccines has focused on the question of whether researchers can develop an effective vaccine in record time. But maybe we should start asking another question as well: Will enough Americans actually get the vaccine for it to be effective? “It’s not a vaccine that will save us,” says Harvard Global Health Institute director Ashish Jha. “It’s vaccination.” For a COVID-19 vaccine to actually stop the pandemic, scientists estimate that at least 60 percent of the population — and probably more like 75 or 80 percent — would need to be vaccinated, a number that depends on many factors, including the efficacy of the vaccine itself and how widely the virus has already spread. With that in mind, Yahoo News and YouGov have been polling the American people for the past few months.

President Trump takes executive action after stimulus talks breakdown. And as more schools report coronavirus cases, parents and teachers are faced with difficult decisions. Whitmer's number two and his next door neighbor weighs in on the veepstakes. Plus, a progressive scores an upset victory in Missouri—and hope that Joe Biden is listening. On today’s show: Toluse Olorunnipa of the Washington Post and Julie Davis of the New York Times; Indiana School Superintendent Jennifer McCormick; Michigan Lieutenant Governor Garlin Gilchrist and Wisconsin Lieutenant Governor Mandela Barnes; Dr. Ashish Jha of the Harvard Global Health Institute and Dr. Megan Ranney of Brown University; Missouri Congressional Candidate Cori Bush.To learn more about how CNN protects listener privacy, visit cnn.com/privacy

Press conference from the Harvard T.H. Chan School of Public Health with Ashish Jha, the K. T. Li Professor of Global Health and director of the Harvard Global Health Institute. This call was recorded at 11:00 a.m. Eastern Time on Monday, August 3rd.

Heather Stone sits down with Dr. Ashish Jha to discuss the latest facts regarding the COVID-19 situation. Video of this interview can be found on the Mentors and Moguls YouTube Page: https://www.youtube.com/watch?v=ThXf4LrmA_8

The President continues his attacks on mail-in voting - and even muses about delaying the election. Plus, the coronavirus death toll crosses 150,000 - and even as new cases plateau in hard-hit states like Texas and Florida, they're rising across the Midwest. And Joe Biden's search for a running mate enters the home stretch. On today’s show: Former Massachusetts Gov. Deval Patrick and Former Utah Congresswoman Mia Love; Dr. Ashish Jha of the Harvard Global Health Institute and Dr. Megan Ranney of Brown University; CNN’s David Axelrod and Former Executive Director and Counsel to the Congressional Black Caucus Angela Rye; Executive Director of Education Trust-West Elisha Smith Arrillaga; and CNN’s Coy Wire.To learn more about how CNN protects listener privacy, visit cnn.com/privacy

press conference from the Harvard T.H. Chan School of Public Health with Thomas Tsai, assistant professor in the Department of Health Policy and Management and an affiliated faculty of the Harvard Global Health Institute. This call was recorded at 11:30 a.m. Eastern Time on Friday, July 24th.

With 100 days until Election Day, new CNN polling out this morning spells trouble for President Trump's re-election hopes in the battleground states of Arizona, Florida, and Michigan. Plus, the U.S. marks yet another grim milestone in the pandemic crisis -- 4 million confirmed cases, and soon to be 150,000 deaths. Why weren't U.S. leaders better prepared for this summer surge? On today’s show: Maggie Haberman of the New York Times and Toluse Olorunnipa of the Washington Post; Dr. Ashish Jha of the Harvard Global Health Institute and Dr. Megan Ranney of Brown University; CNN’s David Axelrod; Emergency Room Physician Dr. Leanna Wen of the George Washington University School of Public Health; and Mark Zandi of Moody’s Analytics To learn more about how CNN protects listener privacy, visit cnn.com/privacy

In the United States, only 10 states and the District of Columbia are conducting enough tests to help mitigate the spread of COVID-19. The state-specific targets were generated by the Harvard Global Health Institute. Six states, including Minnesota, are considered “close” to reaching their testing targets, and 34 states fall far below the goal. The COVID Tracking Project follows testing data closely and also reports on racial disparities. They found that Black people are 2.5 times more likely to die from COVID-19 than their white peers. In several states, Hispanic and Latinx people are overrepresented, relative to their share of the population, when looking at confirmed cases of COVID-19.  On Thursday, MPR News host Kerri Miller spoke with a public health expert and an infectious disease physician about racial disparities and the role of testing in understanding COVID-19.   Guests: Dr. Manisha Juthani is an infectious disease physician at the Yale School of Medicine. Thomas LaVeist is a professor and dean at Tulane University’s School of Public Health and Tropical Medicine. He also serves as the co-chair of Louisiana’s COVID-19 Health Equity Task Force. Subscribe to the MPR News with Kerri Miller podcast on: Apple Podcasts, Google Podcasts , Spotify or RSS.

Press conference from the Harvard T.H. Chan School of Public Health with Thomas Tsai, assistant professor in the Department of Health Policy and Management and an affiliated faculty member of the Harvard Global Health Institute. This call was recorded at 11:30 am Eastern Time on Friday, July 10

While nations across the world struggle to contain the fallout of the human toll and economic consequences of the COVID-19 pandemic, public health experts such as Dr. Ashish Jha have been at the forefront of research and public policy guidance to public and private institutions dealing with the crisis. He shared insights into epidemiological basis of the pandemic and what policy solutions hold out hope for the future in India. Guest: Ashish Jha, K.T. Li Professor of Global Health at Harvard T.H. Chan School of Public Health, and the Director of the Harvard Global Health Institute. Host: Narayan Lakshman, Associate Editor, The Hindu

Press conference on coronavirus (COVID-19) from the Harvard T.H. Chan School of Public Health with Ashish Jha, K.T. Li Professor of Global Health and director of Harvard Global Health Institute. This call was recorded at 11:30 a.m. Eastern Time on Monday, July 6.

On today's show: We track the state's official COVID-19 numbers, plus highlight a new tool to look at the situation by county across the nation from the Harvard Global Health Institute. This will help us understand things better as Michigan is a geographically large state.  Look up your county: https://globalepidemics.org/ Karen Dybis stops by virtually to talk about the Detroit Kite Festival coming up, a great way to have some fun in a socially-distanced manner. https://detroitonthecheap.com/detroit-kite-festival-encourages-this-years-participants-to-socially-distance/ And of course, we had to ask the author of a book about a drive-in movie theater about Walmart popping them up in parking lots. Karen's book: https://www.karendybis.com/ford-wyoming-drive-in Walmart drive-ins: https://twitter.com/Walmart/status/1278445015870640131?s=20 Then Sven Gustafson and Fletcher Sharpe talk upcoming Detroit City FC men's and women's team news and talk about if we should even do pro sports with the pandemic.  Follow Sven: https://twitter.com/sveng Follow Fletcher: https://twitter.com/SaintFDW

If you've followed sensible, expert advice on the pandemic, you've probably read or seen Ashish Jha in the New York Times, The Atlantic, CNN, Washington Post, and everywhere. On Tuesday he testified to the US Senate.He's Harvard's Global Health Institute's Director. Over 200,000 people have taken his online Harvard courses, which you can for free. Over 80,000 took Ebola, Preventing the Next Pandemic and over 120,000 took Improving Global Health: Focusing on Quality and Safety. As it turns out, we were college teammates on the ultimate frisbee team.I'll link to a few top articles by him. With so many interfaces between the pandemic and us---health, government, research, policy, etc---you can read a lot of his views and experiences from different sources.I wanted to bring the personal side of leading on the front lines and top levels of a pandemic---how do doctors and public health experts feel about people not following advice, facing triage decisions, how to be heard, and what affects a doctor personally. We talk about leadership, the intersection between the pandemic and the environment, which overlaps with his directorship and courses, and more.By the way, he created his Ebola course five years before this pandemic and predicted much of it, as did many. If predicting what's happened so far isn't enough reason to follow his advice, I don't know what is. Let's wear those masksAshish's faculty profileCoronavirus Testing Needs to Triple Before the U.S. Can Reopen, Experts Say, NY Times article quoting AshishIn the W.H.O.’s Coronavirus Stumbles, Some Scientists See a Pattern, NY Times article quoting Ashish Pandemic Expert Dr. Ashish K. Jha ’92: “We Will Get Through This.”How We Beat Coronavirus, The AtlanticHere's the reason we are still shut down right now, CNN video See acast.com/privacy for privacy and opt-out information.

This is Coronavirus 411, the latest COVID-19 info and new hotspots… Just the facts… for Friday June 19th, 2020. California has issued a statewide requirement that masks must be worn in indoor public spaces. The Sherriff of Orange County says he won’t enforce the mandate. In Nebraska, The Governor has threatened to withhold funding from communities that require masks in official buildings, reports The Washington Post. On Wednesday, American Airlines removed a passenger from a flight for refusal to wear a mask. The CDC and WHO both recommend masks, frequent hand washing and social distancing to help prevent the spread of COVID-19. In Springfield Missouri in late May, two hairstylists had symptoms of the virus, but continued to work for over a week and saw up to 140 clients. The stylists and the clients all wore masks. The stylists eventually tested positive, none of the 140 clients did. A report in the New England Journal of Medicine, suggests that blood type could play a role in the severity of the COVID-19 illness, with Type A blood more likely to have a severe reaction and Type O, less likely. More research will be conducted. The Director of the Harvard Global Health Institute warns that unless there are policy changes, the growing number cases in the U.S. could get much bigger, relays CNN. Mississippi reported 381 new cases yesterday, a number of which were tied to fraternity rush parties in Oxford. The Yemen Director of the International Rescue Committee, has raised an alarm about conditions in the country stating “We can't even say how many people have it, because Yemen's health system has effectively collapsed, and the country has extremely limited testing capacity”. Mexico reported its largest daily increase in cases with over 5,000. Citing a steady decrease in cases, The United Kingdom has lowered their COVID-19 alert from 4 to 3. Meaning the virus remains in general circulation. The locations of hotspots and U.S and Country diagnoses in a moment. See acast.com/privacy for privacy and opt-out information.

On Juneteenth, Maria and Julio take time to honor and reflect on what today has meant for Black Americans for decades. They hear from Futuro Media's Amanda Alcántara, who shares her reflections on the historical significance of this day. They also talk about the Supreme Court’s decision to block Trump from ending the Deferred Action for Childhood Arrivals (DACA) program, and they break down which states around the country are seeing spikes in coronavirus cases.ITT Staff Picks: Jelani Cobb dives into Juneteenth and freedom for The New Yorker. He writes, "In honoring that moment, we should recognize a moral at the heart of that day in Galveston and in the entirety of American life: there is a vast chasm between the concept of freedom inscribed on paper and the reality of freedom in our lives."Nicole Narea summarizes what you need to know about the US Supreme Court's ruling on the Deferred Action for Childhood Arrivals (DACA) program for Vox. Ashish Jha, director of the Harvard Global Health Institute writes, "anti-racism demonstrations are the perfect scapegoat for a rise in Covid-19 cases, but science suggests their risks can be mitigated," for The Guardian.Photo Credit: AP Photo/Chris Pizzello See acast.com/privacy for privacy and opt-out information.

Justin is an author, speaker and counselor. He’s been featured on TV and radio for his work as a high school counselor and he’s the author of the book “The New, Complete You Life Between the Lines,” Contact Justin at http://www.mightllc.comReferences.The National Child Traumatic Stress Network - www.NCTSN.org Harvard Global Health Institute - https://globalhealth.harvard.edu/mental-health-covid-19This website has some good scenarios toward the end:https://www.thelily.com/how-to-talk-to-your-friends-about-social-distancing-when-theyre-going-to-bars/https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/managing-stress-anxiety.html

Dr. Ashish Jha, director of the Harvard Global Health Institute, says we've learned a lot about the coronavirus, but there are some important questions that don't have answers.

As protests against police violence enter their third consecutive weekend, another tragedy rocks Atlanta – yet another African American man killed by police. But as Democrats and Republicans in Congress scramble to put forward their plans for reform, the White House and campaign struggle with tone deafness on race. And race becomes a major 2020 issue, as President Trump and Joe Biden send very different messages on the police reform debate gripping the nation. Dana Bash in the anchor chair. On today’s show: Columbia, South Carolina Mayor Stephen Benjamin; Montgomery, Alabama Mayor Steven Reed; former Utah Rep. Mia Love and Oklahoma Democratic Party Chair Alicia Andrews; Dr. Ashish Jha of the Harvard Global Health Institute and Dr. Megan Ranney of Brown University; and Amy Walter of Cook Political Report and Toluse Olorunnipa with the Washington Post.

Dr. Ashish K. Jha, head of the Harvard Global Health Institute, offers information on where we are where we’re going with the COVID-19 outbreak. Some take-aways: Communications missteps by the WHO regarding asymptomatic transmission have been quickly corrected. Yes, you can catch COVID-19 from people who are not showing symptoms. A second wave has begun, particularly in the south and Midwest. And calculations show we’ll reach more than 200,000 COVID-19 related deaths by September. Jha offers advice for parents, teachers and administrators on workable back-to-school scenarios. We know you don’t want to hear it, but COVID-19 will be a fact of global life for the rest of the year until a vaccine becomes widely available.

Hosts Mark Masselli and Margaret Flinter welcome Dr. Ashish Jha, Director of the Harvard Global Health Institute, who is advising state, federal and international governments on Covid-19. He laments the delayed and inadequate response by the federal government to the threat of Covid-19, how failure to deploy a cohesive testing strategy has cost lives, and how an aggressive national approach is needed to safely navigate the way through this pandemic. He predicts the coronavirus will change training of future health professionals, as well as the way the American health care system is run. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play HealthcareNOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

As Americans attempt to return to pre-pandemic habits and activities, COVID-19 continues to spread. More than 20 states have seen a jump in coronavirus cases in the past couple of weeks, and hospitalizations have increased significantly in at least eight. Dr. Ashish Jha, director of the Harvard Global Health Institute, joins Judy Woodruff to discuss how states can balance the risks of reopening. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

As Americans attempt to return to pre-pandemic habits and activities, COVID-19 continues to spread. More than 20 states have seen a jump in coronavirus cases in the past couple of weeks, and hospitalizations have increased significantly in at least eight. Dr. Ashish Jha, director of the Harvard Global Health Institute, joins Judy Woodruff to discuss how states can balance the risks of reopening. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

Philonise Floyd testifies on Capitol Hill one day after his brother George Floyd’s burial in Houston. He asked the House Judiciary Committee to take action on policing in the United States. Anderson speaks to Rep. Sheila Jackson Lee, a Democratic member of the committee, and CNN Chief Political Analyst Gloria Borger.  Amber Ruffin, a comedian and writer for “Late Night with Seth Meyers” speaks to Anderson about the personal, painful, and dangerous interactions she has had with the police as a black woman. CNN’s Gary Tuchman takes us to Camden, New Jersey where several years ago every member of the police department was fired and a new police force was created. Plus, the director of the Harvard Global Health Institute projects another 100,000 people in the United States will die from Covid-19 by September. Dr. Leana Wen talks about the rise in coronavirus cases as states are reopening around the country. “We know how to prevent the next 100,000 deaths, but we are not doing that,” says Dr. Wen. Airdate: June 10, 2020

On this episode Sarah talks with Dr. Ashish Jha, professor of global health at Harvard University and director of the Harvard Global Health Institute (and soon to be dean of the Brown School of Public Health). As the United States reels from the ongoing collision of systemic racism, coronavirus, and economic catastrophe, Sarah and Dr. Jha explore how these issues intersect. They also discuss the effects of absentee national leadership during this crisis, and how to bring science and data back into the center of our nation’s healthcare debate.

The death of an African American man in Minneapolis sparks unrest across the nation. Plus, the striking difference in the leadership campaign put forth by President Trump and former Vice President Joe Biden as the nation grapples with protests and an ongoing pandemic. And, a historic launch into space. On today’s show: CNN's Van Jones and Omar Jimenez; John Eligon of The New York Times; Toluse Olorunnipa of the Washington Post; civil rights attorney and former head of the Minneapolis NAACP Nekima Levy Armstrong; former NASA administrator and astronaut Charles Bolden; and Dr. Ashish Jha of the Harvard Global Health Institute and Dr. Megan Ranney of Brown University.

Americans observe a holiday weekend in the new normal, as President Trump makes places of worship the latest flashpoint in his push to reopen. Plus, the president takes aim at battleground states like Michigan, and at efforts to ramp up vote-by-mail. And several companies are reporting good news on vaccine progress – how optimistic should Americans be? On today’s show: Michigan Lt. Gov. Garlin Gilchrist; Former Massachusetts Gov. Deval Patrick; Former Pennsylvania Sen. Rick Santorum; Vaccine expert Dr. Paul Offit; Moody’s Analystics Chief Economist Mark Zandi; and Dr. Ashish Jha of the Harvard Global Health Institute and Dr. Megan Ranney of Brown University.

This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Ashish Jha, Director of the Harvard Global Health Institute, who is advising state, federal and international governments on Covid-19. He laments the delayed and inadequate response by the federal government to the threat of Covid-19, how failure to deploy a cohesive testing strategy has cost lives, and how an aggressive national approach is needed to safely navigate the way through this pandemic. He predicts the coronavirus will change training... Read More Read More The post How the US Pandemic Preparedness Failed: Harvard’s Dr. Ashish Jha on the Best Way Forward Through Covid-19 appeared first on Healthy Communities Online.

At least three people were wounded in a shooting attack in a shopping and entertainment district near Phoenix. A city in central Michigan faces what officials call a 500-year flood disaster, and the governor is now calling for federal aid. Yesterday, the World Health Organization announced the highest single-day increase in coronavirus cases since the crisis began, bringing the worldwide total to more than 5 million reported cases. As all 50 states slowly reopen, the focus now is on protecting Americans who have not gotten sick. Dr. Ashish Jha, director of the Harvard Global Health Institute, joins us to discuss new studies suggesting people who've recovered from the virus do become immune.

Today, Connecticut begins the long, winding process of reopening. We're kicking off a new series to explore some of the most challenging questions as it plays out. This week, we ask the most pressing question on our minds as the first wave of workers returns to the workplace — is it too soon? Dean Sten Vermund of the Yale School of Public Health and Dr. Tom Tsai of the Harvard Global Health Institute join John Dankosky to discuss. See omnystudio.com/listener for privacy information.

Dr. Ashish Jha, professor of Health Policy at the Harvard T.H. Chan School of Public Health, the Director of the Harvard Global Health Institute, assesses the jumble of different ways states are re-opening from a data perspective, and talks about the latest COVID-19 news.

The experiment in reopening exposes a rift between President Trump and his top health adviser. Meanwhile, with his coronavirus response increasingly under fire, the president is turning to a tried-and-true tactic: attack Obama. Plus, a troubling new development has parents worried about the risk coronavirus poses to their children. On today’s show: Pittsburgh Mayor Bill Peduto; Waukesha, Wisconsin Mayor Shawn Reilly; Dr. Jeffrey Burns of Boston Children’s Hospital, Dr. Ashish Jha of the Harvard Global Health Institute, and Dr. Megan Ranney of Brown University; and Jackie Kucinich of the Daily Beast and Toluse Olorunnipa of the Washington Post

Chris goes one on one with Harvard Global Health Institute director, Dr. Ashish Jha. To learn more about how CNN protects listener privacy, visit cnn.com/privacy

WCBS 880’s Lynda Lopez spoke with Dr. Ashish Jha, a professor of global health at Harvard University and director of the Harvard Global Health Institute, who says the country needs to ramp up testing dramatically. 

Chris goes one on one with Harvard Global Health Institute director, Dr. Ashish Jha.  

Coronavirus hits the West Wing - two White House staffers have tested positive, and three of the nation's top medical experts are now in self-imposed quarantine as a result of possible exposure. Despite that reminder of the continued risk, however, the White House and President Trump are forging ahead with an effort to reopen the country - even as may experts say it's far too soon. Driving that decision - the economic catastrophe gripping the U.S. More than 21 million jobs have been lost in just two months, adding financial uncertainty to American's already high levels of stress and anxiety about the future. On today's show: Michigan Democratic Rep. Debbie Dingell; Dr. Thomas File, president of the Infectious Diseases Society of America; Dr. Ashish Jha of the Harvard Global Health Institute and emergency room physician and Brown University researcher Dr. Megan Ranney; Josh Dawsey of the Washington Post and Julie Hirschfeld Davis of the New York Times; and CNN's Kristin Holmes, Will Ripley, Nick Paton Walsh, Melissa Bell, Ben Wedeman, and Kristie Lee Stout.

Chris goes one on one with Director of Harvard Global Health Institute, Dr. Ashish JhaTo learn more about how CNN protects listener privacy, visit cnn.com/privacy

Chris goes one on one with Director of Harvard Global Health Institute, Dr. Ashish Jha

The dean of Harvard's Public Health Institute wants the CDC to be part of the nation's COVID response. So why isn't the Center for Disease Control playing a starring role? Our expert guest talks about the disbanding, and subsequent un-disbanding of Trump's Coronavirus task force, talks about how to re-open the economy, and learns a thing or two about elevators of all things from a particularly insightful caller. On Today's Show:Dr. Ashish Jha, professor of Health Policy at the Harvard T.H. Chan School of Public Health and the Director of the Harvard Global Health Institute, explains the relationship between the Trump administration and the Centers for Disease Control and Prevention and how it may impact the outcome of the COVID-19 pandemic.

More than 60,000 Americans died from coronavirus in April, but President Trump is fully focused on May - and his push to reopen the country as soon as possible. But that reopening is a 50-state experiment, with mixed signals from the federal government - as the case count continues to climb around the country. And Joe Biden "unequivocally" denies a sexual assault allegation by a former staffer, as Democrats grapple with how to balance their support for him with their advocacy for the "Me Too" movement. On today's show: Dallas Mayor Eric Johnson; Boston Mayor Marty Walsh; Massachusetts Rep. Joe Kennedy III; Dr. Ashish Jha of the Harvard Global Health Institute and emergency room Dr. Megan Ranney; and Lisa Lerer of the New York Times, Toluse Olorunnipa of the Washington Post, and CNN's MJ Lee.

Joe Biden says it never happened. Biden spoke publicly for the first time in response to an accusation from former Senate staffer Tara Reade, who says Biden sexually assaulted her in 1993. How should voters evaluate this allegation? And how does Democratic support for Biden square with Biden’s own expressed standard from the Brett Kavanaugh fight that “you’ve got to start off with the presumption that at least the essence” of these sorts of allegations is real. Dr. Ashish Jha of the Harvard Global Health Institute talks about states easing stay-at-home orders and trying to reopen the economy. We have to do it sooner than later, but do we have what it needs to make that reopening sustainable? Dr. Jha talks about the level of testing we need and if states are ready to trace the contacts of people who test positive for Covid-19. Plus: Justin Amash’s Libertarian bid for president, stay-at-home protests in Michigan, and how hard it can be to access unemployment insurance in certain states

How much more testing is needed? Diane asks Dr. Ashish Jha, director of the Harvard Global Health Institute.

As the U.S. coronavirus death toll approaches the number of Americans killed in the Vietnam War, states are engaged in a delicate balancing act - as some governors and the White House push to reopen the U.S. economy despite the ongoing health risk. Plus, amid continued testing shortages, new research suggests coronavirus arrived in the U.S. far earlier than previously known - a reminder that the fight is far from over. And President Trump's freewheeling, erratic press briefings took a more dangerous turn this week - when he mused aloud about the possibility of ingesting disinfectant to kill the virus, despite the potentially fatal effect that would have. On today's show: Augusta, Georgia Mayor Hardie Davis on his state's rush to reopen; Louisiana Sen. Bill Cassidy on the growing GOP divide over the soaring cost of coronavirus relief; Dr. Ashish Jha of the Harvard Global Health Institute and emergency room Dr. Megan Ranney on the latest medical developments; and the New York Times' Maggie Haberman on the president's mindset. Plus CNN's Sarah Westwood from the White House and David Culver on the ground in Wuhan, China.

Chris goes one on one with Director of Harvard Global Health Institute, Dr. Ashish JhaTo learn more about how CNN protects listener privacy, visit cnn.com/privacy

It feels like we’ve been invaded by an invisible enemy — so scary we don’t even want to go to the grocery store. Inside of hospitals, patients and health care workers are fighting this invasion by wearing layers of protective gear. As a country, we’re dealing with it through social distancing and increased testing … And, it feels a bit like war. All of this got us thinking about the idea of invasion. What happens when you face an outside threat, that’s trying to come in? On this episode, we’ll explore this idea through different lenses. We’ll hear stories about coronavirus invading our bodies. Then, we dig into invasive species, and the pushback against the language we use to describe them. And lastly, we get to invasion on a personal level — inside of our minds, and our homes. Also heard on this week’s episode: Climate change has already started pushing wildlife into new territories — leading to widespread concern over the threat posed by “invasive species.” Susan Phillips reports on how some scientists are rethinking this threat, including whether we should consider it a threat at all. Last year Alex Wolfe and his girlfriend made a big decision: They were finally moving in together. Things were going smooth at first, until they realized they were not alone. Are security cameras making us safer at home — or just more paranoid? Reporter Grant Hill tells the story of how a prank planted a seed of suspicion in his family’s home, and talks with psychologist Pamela Rutledge about why and what we’re hardwired to fear. Microbiologist Carolina Lopez offers a primer on our immune systems’ amazing ability to defend against attacks. She also explains all the ways our bodies are — and aren’t — prepared to fight off coronavirus. Can you stop a virus from invading? We talk with Ashish Jha, director of the Harvard Global Health Institute, about what we can do better to halt the spread of the coronavirus in our communities. Disease outbreaks can make people suspicious of others or more likely to cast blame. Public health historian Michael Yudell walks us through some past examples of when racism, discrimination, and fear bubbled up to the surface during times of crisis.

Chris goes one on one with Director of Harvard Global Health Institute, Dr. Ashish Jha

Inside the push to reopen the U.S. economy. The president wants states to get started back up ASAP - but governors are not so sure. Plus, the president makes sweeping declarations of his absolute authority, only to walk it back days later. And all the while, he bristles at criticism that his administration mishandled the coronavirus response. And Democratic leaders line up behind Joe Biden - even as the presumptive nominee struggles for visibility amid a historic pandemic. On today's show: Rhode Island Gov. Gina Raimondo on her strategy to confront coronavirus in her state; Houston, Texas Mayor Sylvester Turner on if his city is nearing its peak. Plus the latest on the medical front with Dr. Ashish Jha of the Harvard Global Health Institute and emergency room physician Dr. Megan Ranney; presidential historian Douglas Brinkley on the president's handling of the crisis; Jonathan Martin of the New York Times and CNN political commentator Jen Psaki on the challenges facing Joe Biden; and CNN's Kaitlan Collins live from the White House.

In this episode of Stratfor's Pen and Sword podcast, host Fred Burton speaks to serial entrepreneur, Brett Hurt. Hurt's latest startup is data.world, a Public Benefit Corporation focused on data and analysis that also includes the world's largest collaborative public data catalog. Data.world is using its platform to help fight the COVID-19 virus, collecting and sharing data from sources like Johns Hopkins, Harvard Global Health Institute, WHO, and individuals. In this conversation, the topics range from how anyone can benefit from and contribute to the COVID-19 data hub to how to weather the nation's biggest downturn in nearly a century. Subscribe to Stratfor Worldview for the latest intelligence on the coronavirus.

Who better to guide us through this darkness than Noam Chomsky? The esteemed linguist, author, and political activist joins us this week to provide a historical perspective to the pandemic (44:02). He also offers his diagnosis of the Trump administration and its failure to effectively respond to COVID-19. At 91, Chomsky is a beacon of hope in these trying times. Before speaking with Noam, Sam calls up Dr. Ashish Jha, Director of Harvard Global Health Institute (2:57) to walk us through life on the front-lines, inside hospitals, when we can expect to return to normal, and how we can ultimately beat this virus.

A grim Easter Sunday -- the coronavirus numbers are staggering, and the global challenge is overwhelming. But as the case curve begins to flatten here at home, President Trump pushes to restart the economy. Plus, as the death toll in the U.S. continues to climb, African Americans take a disproportionate hit. And the third time is the charm for Joe Biden - with Bernie Sanders bowing out, the former vice president becomes the presumptive Democratic nominee. On today's show: Washington, D.C. Mayor Muriel Bowers on the fight to bend the curve in the nation's capital; former Obama senior adviser David Axelrod on Joe Biden's VP hunt and the challenges of campaigning in the age of coronavirus; Dr. Ashish Jha of the Harvard Global Health Institute and ER Dr. Megan Ranney on the medical challenges still remaining; the Wall Street Journal's Alexis Glick on the economic fallout; and NPR's Tamara Keith and Josh Dawsey of the Washington Post on the president's political calculations.

The coronavirus case count and death toll continues its depressing climb - globally and here in the United States. As states brace for the surge of cases, President Trump downplays shortages and insists supplies are coming - but those on the front line ask, when? And the mounting economic shock: millions of jobs gone, and no end in sight. On today's show: the view from the frontlines with Dr. Ashish Jha of the Harvard Global Health Institute and emergency room physician Dr. Megan Ranney and making sense of the economic aftershocks with Mark Zandi of Moody's and CNN's Christine Romans. Plus, evaluating the Trump administration's response with former FEMA Administrator Craig Fugate and the president's constantly changing tone with Maggie Haberman of the New York Times and CNN's David Gergen. And, a look at practicing faith in the time of coronavirus with Rachel Wyatt, a U.S. missionary living in Tanzania.

Coronavirus continues its march around the globe, with the U.S. passing one grim milestone after another - and topping the world in the total number of cases. The result: sweeping new restrictions here at home, and tension at the top as governors demand more help - and get under the president's skin. And on the front lines, doctors face a growing equipment shortage, as Americans look to the government for support as they grapple with historic economic uncertainty. Plus, with cases spiking in Michigan, a look at what's being done with freshman Democratic Congresswoman Haley Stevens. Featuring reporting from CNN's Kaitlan Collins at the White House, Jason Carroll in New York, and Ed Lavandera in New Orleans; medical perspective from Dr. Ashish Jha of the Harvard Global Health Institute and Dr. Megan Ranney of Brown University; and the view from the American heartland under coronavirus with the Washington Post's Holly Bailey.

After the devastating Ebola virus outbreak beginning in 2014, several public health experts predicted that a pandemic of some kind lay ahead – it was not a case of if, but when. Dr. Ashish Jha, director of the Harvard Global Health Institute and professor of Global Health at Harvard T.H. Chan School of Public Health, was one of those people. He even taught a course about what it would take to prevent the next major infectious disease outbreak. Jha says we have the tools at our disposal to confront and eventually combat the novel coronavirus pandemic - we just need to be willing to work together to use them.

In an interview with WHAV's Win Damon this morning, Congresswoman Lori Trahan discussed the federal government's response to COVID-19 and invited residents to participate in a Tele-Town Hall this afternoon to learn more.Joining Trahan will be Jody White, president and CEO of Lowell General Hospital and Circle Health and chairman of the Massachusetts Health and Hospital Association; Dr. Dan Berlowitz, chair, Department of Public Health at UMass Lowell and professor of Medicine at Boston University; and Dr. Ashish Jha, director, Harvard Global Health Institute and K.T. Li Professor of Global Health at Harvard University.The Tele-Town Hall takes place this afternoon, Friday, March 20, at 5 p.m. Those wishing to listen in may dial 855-614-0157. Those with questions may call 978-459-0101 or visit Trahan.House.Gov.Support the show (https://whav.net/become-a-whav-member/)

The COVID-19 outbreak has caused markets to collapse and worldwide health systems to become overwhelmed. When there’s a global pandemic, it’s nice to hear from the steady, transparent and yes even reassuring voice of experts on the front lines. We spoke to Dr. Ashish K. Jha, faculty director of the Harvard Global Health Institute. Dr. Jha’s recent appearance on the PBS Newshour caused reverberations throughout the federal and state response system. Here's his update.

In this special episode, Director of the Harvard Global Health Institute, Dr. Ashish Jha, joins Adam to explain the reality and dispel myths about the coronavirus pandemic, what must be done to combat the illness, and how long the road ahead truly is.

Dr. Ashish Jha is the Director of Harvard Global Health Institute and a Professor at Harvard T. H. Chan school of public health. If you've turned on your TV over the past few days, you've likely seen him discussing COVID-19. Today he joins us to talk about how the coronavirus spread; the necessity for social distancing; elderly discrimination; what we can learn from the Spanish Flu of 1918; and plenty advice on how to best keep you and your family safe in this critical moment.“We’ve got a common enemy and we are going to fight and we are going to win”, he says. To learn more about Dr. Jha and his work, visit our site www.talkeasypod.com.

The latest on the novel coronavirus crisis, as global governments impose new restrictions aimed at limiting a pandemic that has surpassed 152,000 cases and now claimed nearly 6,000 lives worldwide. Here at home, President Trump declares a national emergency, but his constant misstatements about the threat posed by the virus has markets - and the country - on edge. And as Americans adjust to the new normal, so too are presidential candidates - as the coronavirus upends the 2020 presidential race. Today's panel: Lisa Lerer of the New York Times, Seung Min Kim of the Washington Post, Margaret Talev of Axios, and CNN's Kaitlan Collins and Arlette Saenz. Plus Dr. Ashish Jha of the Harvard Global Health Institute, and CNN's Polo Sandoval and Melissa Bell on the ground in New York and Rome.

America adjusts to our fast changing new normal -- schools closed, sporting events canceled and fast rising numbers in the rush to count coronavirus cases. The Trump White House tries to address a major coronavirus shortcoming, taking several new steps designed to accelerate production and availability of tests. The President is expected to make an emergency declaration at an afternoon news conference. And Democratic Presidential candidates Joe Biden and Bernie Sanders criticize the administration's response, as they struggle to keep their campaigns moving forward amid the crisis. Today's Panel: CNN's Vivian Salama, POLITICO's Melanie Zanona, and Paul Kane and Matt Viser with The Washington Post Also on the program: CNN's Drew Griffin, Brynn Gingras, Dan Simon, Barbie Nadeau and Kylie Atwood, plus Dr. Ashish Jha with Harvard Global Health Institute, Lisa Delpy Neirotti with George Washington University, and Jeanna Smialek with The New York Times

Featured Interview: World Bank's pandemics bonds Guest: Olga Jonas, Senior Fellow, Harvard Global Health Institute, Former Economic Advisor at World Bank

… it’s bad. There are now 80,000 cases of COVID-19 worldwide, including new diagnoses in Italy, Iran and South Korea. This news has sent American markets plummeting, and prompted the CDC to warn of an outbreak Tuesday morning, but the World Health Organization isn’t declaring a pandemic yet. Here to talk with us about pandemics past and their economic effects is is Olga Jonas, a senior fellow with the Harvard Global Health Institute. Subscribe to the “Make Me Smart” newsletter at Marketplace.org/newsletters and tell your Echo device to “make me smart” for daily explainers.

Back in 2017, the World Bank issued the world's first pandemic bonds. The bonds are meant to shift some of the financial risk of a global pandemic on to investors, but they've been criticized for having 'triggers' that are too tough to generate payouts. Now, as the coronavirus outbreak continues to spread, it's worth looking at how these bonds are structured and what they can tell us about the future of public-private partnerships in finance. In this episode of Odd Lots, we speak with Olga Jonas of the Harvard Global Health Institute, and a former economist at the World Bank with significant pandemic experience. She gives us her take on the bonds as well as the economic impact of big epidemics.

Dr. Renee Salas is an affiliated faculty member at the Harvard Global Health Institute and an emergency medicine physician at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R.N. Salas and C.G. Solomon. The Climate Crisis — Health and Care Delivery. N Engl J Med 2019;381:e13. C. Sorensen and R. Garcia-Trabanino. A New Era of Climate Medicine — Addressing Heat-Triggered Renal Disease. N Engl J Med 2019;381:693-696. G. McCarthy and A. Bernstein. Combating EPA Rollbacks — Health Care’s Response to a Retreat on Climate. N Engl J Med 2019;381:696-698. R.N. Salas, D. Malina, and C.G. Solomon. Prioritizing Health in a Changing Climate. N Engl J Med 2019;381:773-774.

Listen NowThis past June 4th the 9th Circuit Court heard oral arguments concerning Juliana v. the US, a case filed in 2015 by 21 children seeking a jury verdict on whether the US government, by failing to address the climate crisis, is protecting the plaintiff's rights to life, liberty and the pursuit of happiness.  In its defense the US is arguing these children, now young adults, have “no fundamental constitutional right” to a “climate system capable of sustaining human life.”  In a May 30th essay published in The New England Journal of Medicine Dr. Salas and two colleagues agreed with the plaintiffs concluding , “As the Juliana plaintiffs argue - and we agree - climate change is the greatest public health emergency in our time and is particularly harmful to fetuses, infants, children and adolescent.” (Listeners may be aware this is my 7th climate crisis related interview since October.)During this 26 minute interview Dr. Salas discusses her related research work, the amicus brief she and her colleagues forwarded in support of Juliana plaintiffs and other related litigation filed world wide.  Moreover, Dr. Salas explains the numerous adverse health effects children are suffering via the climate crisis including various birth defects, heart, lung and neurodevelopment illnesses, vector-borne diseases, harms from high heat and wildfire exposure, cognitive, behavioral and mental health effects, contaminated water, and numerous others.  She discusses what parents need to know or can do to protect their children and the extent the health care industry needs to (better) address its own contribution to greenhouse gas emissions/pollution or global warming. Dr. Renee Salas is Affiliated Faculty and a Burke Fellow at the Harvard Global Health Institute.   Her research addresses how climate change is impacting the healthcare system and developing evidence-based adaptation.She is also a practicing physician in the Department of Emergency Medicine at Massachusetts General Hospital and on faculty at Harvard Medical School.  Dr. Salas served as the lead author on the 2018 Lancet Countdown on Health and Climate Change U.S. Brief and will again in 2019.   She lectures on climate and health nationally and internationally, has published in numerous scholarly journals and is the founder and past Chair of the Climate Change and Health Interest Group at the Society of Academic Emergency Medicine.  Dr. Salas received her Doctor of Medicine from the Cleveland Clinic Lerner College of Medicine with a Master of Science in Clinical Research from the Case Western Reserve University School of Medicine.  She also holds a Master of Public Health from the Harvard T.H. Chan School of Public Health with a concentration in environmental health.Renee Salas, Wendy Jacobs and Frederica Perera's New England Journal of Medicine essay, "The Case of Juliana v US - Children and the Health Burdens of Climate Change," is at: https://www.nejm.org/doi/full/10.1056/NEJMp1905504 The video of the 9th Circuit Juliana v the US oral argument is at: https://www.ca9.uscourts.gov/media/view_video.php?pk_vid=0000015741&fbclid=IwAR3K3vnHCO4M2KlcMZ1NSQ4ua1ZZhpdyA-hONwyj6N7uS0u1X5ojmuVVkCcThe amicus brief filed in support of the Juliana plaintiffs by 13 medical societies and over 65 medical professionals is at: http://clinics.law.harvard.edu/environment/files/2019/03/Juliana-Public-Health-Experts-Brief-with-Paper-Copy-Certificate.pdf. Again, my related essay, "Can the Climate Crisis Continue to Go Begging?" is at: https://www.3quarksdaily.com/3quarksdaily/2019/06/can-the-climate-crisis-continue-to-go-begging.html. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thehealthcarepolicypodcast.com

In the second part of his keynote address at the 2019 AMA State Advocacy Summit, Ashish K. Jha, MD, MPH, director of Harvard Global Health Institute, talks about the tradeoff of positive and negative outcomes stemming from high prices in America’s health care sector. You can follow along with Dr. Jha by viewing his presentation deck at ama-assn.org/jha-mm and subscribe for exclusive advocacy news at ama-assn.org/advocacy-update.

In the first part of his keynote address at the 2019 AMA State Advocacy Summit, Ashish K. Jha, MD, MPH, director of Harvard Global Health Institute, discusses why the U.S. spends so much more on health care than other countries and reviews data on potential sources for this high spend. You can follow along with Dr. Jha by viewing his presentation deck at ama-assn.org/jha-mm and subscribe for exclusive advocacy news at ama-assn.org/advocacy-update.

When many people think of design they’re probably picturing a product, like a new smartphone or car. But the design principles that lead to the creation of those products—such as the focus on human behavior or the use of prototyping—can also be harnessed to tackle complex public health challenges. In this week’s episode you’ll learn how one of the world’s top public health researchers, Ashish Jha, dean for global strategy at Harvard T.H Chan School of Public Health and director of the Harvard Global Health Institute, and one of the world’s foremost design experts, Patrick Whitney, professor in residence in the Department of Health Policy and Management, have teamed up to think about how design methods can be used to address issues ranging from the opioid epidemic to the future of hospitals. Full Transcript: hsph.me/design-pod This episode is a collaboration with Harvard Global Health Institute.

March 22, 2019 — When many people think of design they're probably picturing a product, like a new smartphone or car. But the design principles that lead to the creation of those products—such as the focus on human behavior or the use of prototyping—can also be harnessed to tackle complex public health challenges. In this week's episode you'll learn how one of the world's top public health researchers, Ashish Jha, dean for global strategy at Harvard T.H Chan School of Public Health and director of the Harvard Global Health Institute, and one of the world's foremost design experts, Patrick Whitney, professor in residence in the Department of Health Policy and Management, have teamed up to think about how design methods can be used to address issues ranging from the opioid epidemic to the future of hospitals. This episode is a collaboration with Harvard Global Health Institute. You can subscribe to Harvard Chan: This Week in Health by visiting iTunes or Google Play and you can listen to it by following us on Soundcloud, and stream it on the Stitcher app or on Spotify. Learn more Rethinking WHO: Students see a bigger role for frontline health workers (Harvard Chan School news)

Ashish Jha has spent years sounding the alarm about the Hospital Readmissions Reduction Program — an Obamacare policy intended to encourage hospitals to provide better care. But Jha argues the program instead put patients at risk, and new data suggests he might be right. Jha, the director of the Harvard Global Health Institute, joins POLITICO's Dan Diamond to discuss the readmissions policy and the latest data. Jha also reflects on the Trump administration’s approach to global health and how his perspective has evolved over the past two years. MENTIONED ON THE SHOW Jha’s February 2017 appearance on POLITICO “Pulse Check,” where he discussed his career and global health priorities. A JAMA study in December found a link between the readmissions policy and rising mortality. Harvard researchers this month also concluded that Medicare has overstated the benefits of its readmissions policy. Yale’s Harlan Krumholz helped develop the policy and has extensively defended it, including in this 2017 comment in JAMA. Writing in the New York Times, Paula Span reviewed the latest arguments and data. HHS Secretary Alex Azar has a unique perspective: Even as he oversees a policy to cut readmissions, Azar was readmitted to the hospital last year while suffering an intestinal infection.

Oral rehydration solution (ORS)—a mixture of water, sugar, and salt that is administered as part of oral rehydration therapy (ORT)—is credited with preventing tens of millions of deaths from cholera and other diarrheal diseases. In this week's podcast you'll hear from two scientists who helped bring this simple, low-tech, and cost-effective treatment into worldwide use. Richard Cash, senior lecturer on global health at Harvard T.H. Chan School of Public Health, and David Nalin, professor emeritus at Albany Medical College, collaborated on groundbreaking clinical studies showing that ORT was remarkably effective in reversing dehydration. This episode is a collaboration with Harvard Global Health Institute.

December 19, 2018 — Oral rehydration solution (ORS)—a mixture of water, sugar, and salt that is administered as part of oral rehydration therapy (ORT)—is credited with preventing tens of millions of deaths from cholera and other diarrheal diseases. In this week's podcast you'll hear from two scientists who helped bring this simple, low-tech, and cost-effective treatment into worldwide use. Richard Cash, senior lecturer on global health at Harvard T.H. Chan School of Public Health, and David Nalin, professor emeritus at Albany Medical College, collaborated on groundbreaking clinical studies showing that ORT was remarkably effective in reversing dehydration. This episode is a collaboration with Harvard Global Health Institute. You can subscribe to Harvard Chan: This Week in Health by visiting iTunes or Google Play and you can listen to it by following us on Soundcloud, and stream it on the Stitcher app or on Spotify. Learn more A lifesaving therapy—and the researcher who helped launch it Watch video of a recent event honoring Richard Cash

There's a lot going on in the world at the moment - Ebola's back, Puerto Rico is without power and the official estimations of death following the hurricane are being challenged. The WHO's just met to decide what to do about it all, as well as sorting out universal healthcare, access to medicines, eradicating polio, etc etc. To make sense of that a little, we grabbed Ashish Jha - Director of the Harvard Global Health Institute to shed some light into how decisions about global health are made, and why he tries to see the world as it actually is - not how he wishes it would be. Reading list: Mortality in Puerto Rico after Hurricane Maria https://www.nejm.org/doi/full/10.1056/NEJMsa1803972 https://www.bmj.com/universal-health-coverage